Location History:
- Cambridge, MA (US) (2012 - 2015)
- Rindge, NH (US) (2008 - 2019)
Company Filing History:
Years Active: 2008-2019
Title: Mark Gabriel Palermo - Innovating Towards Better Cancer Treatment
Introduction: Mark Gabriel Palermo, a prolific inventor based in Rindge, NH (US), has made significant contributions in the field of pharmaceuticals and cancer treatment with 11 patents to his name.
Latest Patents:
- Compounds and compositions for inhibiting the activity of SHP2: Palermo's invention focuses on compounds for inhibiting the activity of SHP2, which has implications in the treatment of various disorders, including cancer.
- 4-piperidinyl compounds for use as tankyrase inhibitors: His work on tankyrase inhibitors shows promise in the treatment of Wnt signaling and tankyrase 1 and 2 signaling related disorders.
Career Highlights: Palermo has worked with renowned companies such as Novartis AG and Aventis Pharma S.A., showcasing his expertise and dedication to innovation in the pharmaceutical industry.
Collaborations: Throughout his career, Palermo has collaborated with talented individuals like Zhuoliang Chen and Christopher Sean Straub, further enriching the depth of his research and inventions.
Conclusion: Mark Gabriel Palermo's inventive spirit and commitment to improving cancer treatment through innovative pharmaceutical solutions are evident in his impressive patent portfolio and collaborations with leading industry experts. His contributions continue to pave the way for advancements in treating complex disorders like cancer.